Market Place
Sourcing Support
Nordic Group Introduces Lacrifill® Gel at AAO 2024
17 Oct 2024 //
BUSINESSWIRE
Alex Therapeutics Partners With Navamedic On Parkinson`s Disease App
12 Sep 2024 //
PR NEWSWIRE
Nordic Wellness Expands Portfolio With Acquisition of Peak Flow
27 Jun 2024 //
ACCESSWIRE
Nordic Bioproducts Receives EXCiPACT Certification for MCC Production
27 Jun 2024 //
PHARMABIZ
Nordic Pharma Launches LACRIFILL® Canalicular Gel For Dry Eye
29 May 2024 //
BUSINESSWIRE
Nordic to Present Data on LACRIFILL, Novel Therapy for Dry Eye, at the Meeting
02 Apr 2024 //
BUSINESSWIRE
Nordic Appoints Oculoplastic Surgeon, John P. Fezza to Medical Advisory Board
14 Mar 2024 //
BUSINESSWIRE
Nordic Pharma Completes Acquisition of Visant Medical
18 Dec 2023 //
BUSINESSWIRE
NORDIC PHARMA Submits MAA of Methotrexate Autoinjector to Health Canada
30 Mar 2022 //
BUSINESSWIRE
European Commission approves Teysuno in metastatic colorectal cancer
31 Jan 2022 //
PRNEWSWIRE
Nordic Nanovector completes patient into Ph1 trial of Betalutin®
01 Dec 2020 //
PRESS RELEASE
Nordic Nanovector completes enrolment into second safety cohort of follicular lymphoma patients
19 Nov 2020 //
PRESS RELEASE
Nordic Nanovector begins patient enrollment PARADIGME ph2b trial of Betalutin
25 Jun 2018 //
PHARMABIZ
US FDA grants fast track status to Nordic`s Betalutin for patients lymphoma
12 Jun 2018 //
PHARMABIZ
Nordic Nanovector Announces PARADIGME Trial Approved to Start in Norway
29 May 2018 //
PR NEWSWIRE
Nordic Nanovector Provides Update on the PARADIGME Clinical Trial
04 Apr 2018 //
PRNEWSWIRE
AZ’s Imfinzi paired with Bavarian Nordic’s CV301 vaccine
28 Feb 2018 //
PMLIVE
EU Ombudsman confirms EMA`s correct handling of declared interests
27 Nov 2017 //
EMA
Could RSV be Bavarian Nordic`s savior after Prostvac flop?
14 Nov 2017 //
FIERCE PHARMA
Vaccine order boosts Bavarian Nordic after cancer drug flop
28 Sep 2017 //
REUTERS
Bavarian Nordic hit by cancer immunotherapy failure
18 Sep 2017 //
PHARMA TIMES
Bavarian Nordic tanks after BMS-partnered vaccine flunks phase 3
15 Sep 2017 //
FIERCE BIOTECH
Kerrisdale 2-0 this week: Bavarian Nordic’s cancer vaccine is a bust in PhIII
14 Sep 2017 //
ENDPTS
Bavarian Nordic, J&J team up in $879M HIV and HBV vaccines deal
28 Jul 2017 //
FIERCE PHARMA
Bristol-Myers, Nordic Bioscience To Develop Fibrosis Biomarker Technology
18 Apr 2017 //
NASDAQ
UK launch for Nordic’s novel methotrexate pen
04 Apr 2017 //
PHARMA TIMES
Bavarian Nordic, Roche to test bladder cancer combo
14 Mar 2017 //
PHARMATIMES
Cancer player Nordic Nanovector stokes takeover talk
21 Feb 2017 //
FIERCE BIOTECH
Nordic Group B.V. Nordimet (Methotrexate) Approved In Europe
29 Sep 2016 //
EUROPE
Nordic Nanovector wraps up enrollment in pre-dosed arms of NHL trial
18 Aug 2016 //
FIERCE BIOTECH
